Fulcrum Therapeutics, Inc.Fulcrum Therapeutics, Inc.Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics, Inc.

No trades
See on Supercharts

Price target

13.250.00 0.00%
The 8 analysts offering 1 year price forecasts for FULC have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to FULC in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

FULC EPS for the last quarter is −0.40 USD despite the estimation of −0.43 USD. In the next quarter EPS is expected to reach −0.44 USD. Track more of Fulcrum Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Fulcrum Therapeutics, Inc. revenue is expected to reach ‪416.67 K‬ USD. Check out Fulcrum Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, FULC price target is 13.25 USD with a max estimate of 19.00 USD and a min estimate of 5.00 USD. Check if this forecast comes true in a year, meanwhile watch Fulcrum Therapeutics, Inc. stock price chart and keep track of the current situation with FULC news and stock market news.
We've gathered opinions of 8 analysts rating FULC stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.